切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2018, Vol. 06 ›› Issue (01) : 15 -18. doi: 10.3877/cma.j.issn.2095-5820.2018.01.005

所属专题: 文献

专题笔谈

脓毒症对患者生存健康的长期影响
宁永忠1,(), 赵敬焕1, 李祥1, 傅琪瑶1, 王俊文1   
  1. 1. 100022 北京,清华大学附属垂杨柳医院检验科
  • 收稿日期:2017-08-23 出版日期:2018-02-28
  • 通信作者: 宁永忠

Long-term effect of sepsis on the survival of the patients

Yongzhong Ning1,(), Jinhuan Zhao1, Xiang Li1, Qiyao Fu1, Junwen Wang1   

  1. 1. Department of Laboratory Medicine, Chuiyangliu Hospital affiliated to Tsinghua University, Beijing 100022, China
  • Received:2017-08-23 Published:2018-02-28
  • Corresponding author: Yongzhong Ning
  • About author:
    Corresponding author: Ning Yongzhong, Email:
引用本文:

宁永忠, 赵敬焕, 李祥, 傅琪瑶, 王俊文. 脓毒症对患者生存健康的长期影响[J]. 中华临床实验室管理电子杂志, 2018, 06(01): 15-18.

Yongzhong Ning, Jinhuan Zhao, Xiang Li, Qiyao Fu, Junwen Wang. Long-term effect of sepsis on the survival of the patients[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2018, 06(01): 15-18.

脓毒症始于感染,通过感染导致宿主反应失调,引起多器官功能障碍,以至威胁生命。研究发现,脓毒症患者晚期病死率明显增加;由于再次感染而再次入院的几率也增加,且感染的病原有一定的特点。另外,脓毒症长期影响还可能导致患者不同程度的认知损伤,包括抑郁和谵忘;脓毒症还是引发心血管疾病的风险因素。及时抢救脓毒症患者可减少其短期器官功能障碍,减少病死率,以及减少患者生存健康的长期影响。

Sepsis leads to multi-organ dysfunction that threatens patients′life. It is caused by a deregulated host response to infection. It has been found that the late mortality of septic was significantly increased; the probability of rehospitalisation due to recurrent infection was also increased, and the infection pathogen of sepsishad certain characteristics. In addition, sepsis can cause cognitive impairment including depression and delirium. Sepsis is also the risk factor of subsequent cardiovascular diseases. Timely rescue to reduce short-term organ dysfunction can reduce mortality and reduce long-term effects of sepsis.

1
Prescott HC, Osterholzer JJ, Langa KM, et al. Late mortality after sepsis: propensity matched cohort study[J]. BMJ, 2016,353:i2375.
2
Agarwal A, Agarwal A. Infection associated secondary hemophagocytic lymphohistiocytosis in sepsis syndromes - A tip of an iceberg[J]. J Assoc Physicians India, 2016,64(10):44-50.
3
Shankar-Hari M, Rubenfeld GD. Understanding long-term outcomes following sepsis: Implications and challenges[J]. Curr Infect Dis Rep, 2016,18(11):37.
4
Shankar-Hari M, Ambler M, Mahalingasivam V, et al. Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies[J]. Crit Care, 2016,20:101.
5
Ou SM, Chu H, Chao PW, et al. Long-term mortality and major adverse cardiovascular events in sepsis survivors. A nationwide population-based study[J].Am J Respir Crit Care Med, 2016,194(2):209-217.
6
Stevenson EK, Rubenstein AR, Radin GT, et al. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis[J]. Crit Care Med, 2014,42(3):625-631.
7
Krumholz HM, Lin Z, Keenan PS, et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia[J]. JAMA, 2013,309(6):587-593.
8
Borzecki AM, Chen Q, Restuccia J, et al. Do pneumonia readmissions flagged as potentially preventable by the 3M PPR software have more process of care problems? A cross-sectional observational study[J]. BMJ Qual Saf, 2015,24(12):753-763.
9
Prescott HC, Langa KM, Liu V, et al. Increased 1-year healthcare use in survivors of severe sepsis[J]. Am J Respir Crit Care Med, 2014,190(1):62-69.
10
Prescott HC, Langa KM, Iwashyna TJ, et al. Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions[J]. JAMA, 2015,313(10):1055-1057.
11
Jones TK, Fuchs BD, Small DS, et al. Post-acute care use and hospital readmission after sepsis[J]. Ann Am Thorac Soc, 2015,12(6):904-913.
12
Sun A, Netzer G, Small DS, et al. Association between index hospitalization and hospital readmission in sepsis survivors[J]. Crit Care Med, 2016,44(3):478-487.
13
Wang T, Derhovanessian A, De Cruz S, et al. Subsequent infections in survivors of sepsis: epidemiology and outcomes[J]. J Intensive Care Med, 2014,29(2):87-95.
14
Zhao GJ, Li D, Zhao Q, et al. Incidence, risk factors and impact on outcomes of secondary infection in patients with septic shock: an 8-year retrospective study[J]. Sci Rep, 2016,6:38361.
15
Walton AH, Muenzer JT, Rasche D, et al. Reactivation of multiple viruses in patients with sepsis[J]. PLoS One, 2014,9(2):e98819.
16
Lopez Roa P, Hill JA, Kirby KA, et al. Coreactivation of human herpesvirus 6 and cytomegalovirus is associated with worse clinical outcome in critically ill adults[J]. Crit Care Med, 2015,43(7):1415-1422.
17
Fromentin DM, Gauzit R, Gille B, et al. First description of herpes simplex virus type 1 epididymo-orchitis: A new clinical form of herpes simplex virus infection during septic shock[J]? IDCases, 2016,6:26-28.
18
Lachance P, Chen J, Featherstone R, et al. Impact of cytomegalovirus reactivation on clinical outcomes in immunocompetent critically ill patients: protocol for a systematic review and meta-analysis[J]. Syst Rev, 2016,5(1):127.
19
Otto GP, Sossdorf M, Claus RA, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate[J]. Crit Care, 2011,15(4):R183.
20
Guirgis FW, Brakenridge S, Sutchu S, et al. The long-term burden of severe sepsis and septic shock: sepsis recidivism and organ dysfunction[J]. J Trauma Acute Care Surg, 2016,81(3):525-532.
21
Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis[J]. JAMA, 2010,304(16):1787-1794.
22
Shah FA, Pike F, Alvarez K, et al. Bidirectional relationship between cognitive function and pneumonia[J]. Am J Respir Crit Care Med, 2013,188(5):586-592.
23
Davydow DS, Hough CL, Langa KM, et al. Symptoms of depression in survivors of severe sepsis: a prospective cohort study of older Americans[J]. Am J Geriatr Psychiatry, 2013,21(9):887-897.
24
Klein Klouwenberg PM, Zaal IJ, Spitoni C, et al. The attributable mortality of delirium in critically ill patients: prospective cohort study[J]. BMJ, 2014,349:g6652.
25
Tsuruta R, Oda Y. A clinical perspective of sepsis-associated delirium[J]. J Intensive Care, 2016,4:18.
26
Yende S, Linde-Zwirble W, Mayr F, et al. Risk of cardiovascular events in survivors of severe sepsis[J]. Am J Respir Crit Care Med, 2014,189(9):1065-1074.
27
Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease[J]. JAMA, 2015,313(3):264-274.
28
Jafarzadeh SR, Thomas BS, Warren DK, et al. Longitudinal study of the effects of bacteremia and sepsis on 5-year risk of cardiovascular events[J]. Clin Infect Dis, 2016,63(4):495-500.
29
Dalager-Pedersen M, Søgaard M, Schønheyder HC, et al. Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study[J]. Circulation, 2014,129(13):1387-1396.
30
Shih CJ, Chao PW, Ou SM, et al. Long-term risk of cardiovascular events in patients with chronic kidney disease who have survived sepsis: anationwide cohort study[J]. J Am Heart Assoc, 2017,6(2). pii: e004613.
31
Delano MJ, Ward PA. The immune system′s role in sepsis progression, resolution, and long-term outcome[J]. Immunol Rev, 2016,274(1):330-353.
32
Suzuki K, Inoue S, Kametani Y, et al. Reduced immunocompetent B cells and increased secondary infection in elderly patients with severe sepsis[J]. Shock, 2016,46(3):270-278.
33
von Bahr V, Hultman J, Eksborg S, et al. Long-term survival in adults treated with extracorporeal membrane oxygenation for respiratory failure and sepsis[J]. Crit Care Med, 2017,45(2):164-170.
34
Linder A, Lee T, Fisher J, et al. Short-term organ dysfunction is associated with long-term (10-Yr) mortality of septic shock[J]. Crit Care Med, 2016,44(8):e728-736.
[1] 徐娟, 孙汝贤, 赵东亚, 张清艳, 金兆辰, 蔡燕. 右美托咪定序贯镇静模式对中深度镇静的机械通气患者预后和谵妄的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 363-369.
[2] 孟建标, 张庚, 焦燕娜. 脓毒症合并心功能障碍患者早期肠道微生态改变的探讨[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 279-285.
[3] 陈宇, 冯芳, 张露, 刘健. 基于生物信息学分析筛选脓毒症心肌病关键致病基因[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 286-291.
[4] 韩媛媛, 热孜亚·萨贝提, 冒智捷, 穆福娜依·艾尔肯, 陆晨, 桑晓红, 阿尔曼·木拉提, 张丽. 组合式血液净化治疗对脓毒症患者血清炎症因子水平和临床预后的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 272-278.
[5] 作者. 脓毒症与脓毒性休克[J]. 中华危重症医学杂志(电子版), 2023, 16(03): 0-.
[6] 莫小乔, 胡喆莹, 廖冬花, 谢天. 脓毒症继发急性肾损伤患者死亡风险预测模型构建及评估[J]. 中华危重症医学杂志(电子版), 2023, 16(03): 198-206.
[7] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[8] 魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[9] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[10] 窦上文, 邓欢, 刘邦锋, 岳高远志, 朱华财, 刘永达. 术前复查尿培养在预测微通道经皮肾镜取石术相关感染并发症中的作用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 361-366.
[11] 李伟, 卓剑, 黄川, 黄有攀. Lac、HO-1、sRAGE、CRP/ALB表达及脓毒症并发ARDS危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 514-516.
[12] 苗软昕, 乔晞. Toll样受体在脓毒症性急性肾损伤中的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 210-214.
[13] 李世明, 黄蔚, 刘玲. HMGB1介导脓毒症相关凝血功能障碍的作用机制及其治疗进展[J]. 中华重症医学电子杂志, 2023, 09(03): 269-273.
[14] 谭睿, 王晶, 於江泉, 郑瑞强. 脓毒症中高密度脂蛋白、载脂蛋白A-I和血清淀粉样蛋白A的作用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(06): 749-753.
[15] 蔡荇, 郑瑞强. 肝素结合蛋白在脓毒症中的应用及研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(04): 487-490.
阅读次数
全文


摘要